Please assess the completion status of the following clinical trial:

Trial Title: Vulnerable Plaque Imaging in NSTEMI

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Prolonged symptoms suspected of cardiac origin (angina pectoris or angina equivalent), and presentation on the cardiac emergency department \<24 hours after symptom onset~* Elevated levels of high-sensitivity troponin T (\>14ng/L; initial blood sample at presentation or a second sample 3 hours after presentation)~* Only patients scheduled for invasive coronary angiography~* Age 18 years - 85 years~* Mentally competent~* Informed written consent~Exclusion Criteria:~* Conservatively managed patients who are not scheduled for invasive coronary angiography~* Refractory angina or on-going severe ischemia requiring immediate invasive coronary angiography~* Patients requiring invasive coronary angiography \< 24 hours after admission~* Hemodynamic instability and cardiogenic shock (mean arterial pressure \< 60 mmHg)~* Severe heart failure (Killip Class ≥ III)~* ST elevation myocardial infarction (ST-elevation in 2 contiguous leads: ≥0.2mV in men or ≥0.15 mV in women in leads V2-V3 and/or ≥0.1 mV in other leads or new left bundle branch block)~* Chest pain highly suggestive of non-cardiac origin (as judged by the cardiac emergency department physician/cardiologist):~* (Suspicion of) acute aortic dissection, acute pulmonary embolism, acute peri-myocarditis~* Life threatening arrhythmias on the cardiac emergency department or prior to presentation (sustained ventricular tachycardia, repetitive non-sustained ventricular tachycardia, ventricular fibrillation, sino-artial or atrio-ventricular block)~* Atrial fibrillation with ventricular rate ≥100 beats per minute (bpm)~* Tachycardia (≥100/bpm)~* Angina pectoris secondary to anaemia (\<5.6 mmol/L), untreated hyperthyroidism, or severe hypertension (\>200/110 mmHg)~* More than mild aortic and mitral valve calcification or stenosis by latest echocardiography~* Pregnancy~* Breast feeding women~* Life expectancy \<2 years (malignancy, etc.)~* Refusal of data storage until 15 years after end of study~* Participation in another investigational study that has not reached its primary endpoint~* Contraindications to cardiac magnetic resonance imaging

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).